ArticleJournal of public health (Oxford, England)2024
Applying an equity lens to social prescribing.
Article in Journal of public health (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Potential harms of social prescribing: a global umbrella review and dark logic model.BMJ open · 2026Pooled it
- A scoping review of the characteristics, responsibilities, implementations and evaluations of digital navigators in healthcare.NPJ digital medicine · 2026Article
- Perspectives of stakeholders in Danish voluntary sports clubs on engaging in potential social prescribing programmes: a qualitative case study.BMC primary care · 2026Article
- Digital social prescribing: a concept analysis.Frontiers in public health · 2026Review
- Integrated arts engagement as preventive infrastructure for active and healthy aging: a conceptual and policy framework.Frontiers in public health · 2026Article
- Identifying social prescribing core outcomes using a Delphi approach: findings and future directions.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2026Article
- From fragmentation to integration: can social prescribing bridge the gap between multimorbidity and mental health in an ageing population?BMJ public health · 2026Review
- Social prescribing for refugee populations: a rapid realist review of international evidence.Frontiers in public health · 2026Review
- Exploring contextual barriers and enablers for the potential involvement of voluntary sports clubs in social prescribing: a qualitative case study in Denmark.BMC primary care · 2025Article
- Stakeholder understanding of social prescribing in England: a qualitative study in primary care.BMC primary care · 2025Article
- Health system lessons from community practice: a qualitative study rethinking the role of social prescribing for refugee populations.Frontiers in public health · 2025Article
- Building common understanding: seeking consensus and defining social prescribing across contexts - a collective commentary on a Delphi study.BMC health services research · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSocial prescribing is often described as an intervention that can help reduce health inequalities yet there is little evidence exploring this. This study aimed to assess the feasibility of accessing and analysing social prescribing (SP) service user data to demonstrate the impact of SP on health inequalities.
methodsThe sample size consisted of records for 276 individuals in Site 1 and 1644 in Site 2. Descriptive analyses were performed to assess the characteristics of people accessing SP, the consistency of data collected and the missingness across both sites.
resultsBoth sites collected basic demographic data (age gender, ethnicity and deprivation). However, data collection was inconsistent; issues included poor recording of ethnicity in Site 2, and for both sites, referral source data and health and well-being outcome measures were missing. There was limited data on the wider determinants of health. These data gaps mean that impacts on health inequalities could not be fully explored.
conclusionsIt is essential that SP data collection includes information on user demographics and the wider determinants of health in line with PROGRESS Plus factors. Considering equity around who is accessing SP, how they access it and the outcomes is essential to evidencing how SP affects health inequalities and ensuring equitable service delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.